Every atomic assertion extracted from the underlying record, ranked by evidence strength.
Humana Inc. completed a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes.
Humana Inc. intends to use the net proceeds for general corporate purposes.
Humana Inc. expects net proceeds of approximately $986 million from the Junior Subordinated Notes Offering.
Goldman Sachs & Co. LLC acted as an active joint book-running manager for Humana Inc.'s Junior Subordinated Notes Offering.
J.P. Morgan Securities LLC acted as an active joint book-running manager for Humana Inc.'s Junior Subordinated Notes Offering.
The repayment of existing indebtedness may include borrowings under Humana Inc.'s commercial paper program.
Mizuho Securities USA LLC acted as an active joint book-running manager for Humana Inc.'s Junior Subordinated Notes Offering.
Truist Securities, Inc. acted as an active joint book-running manager for Humana Inc.'s Junior Subordinated Notes Offering.
Wells Fargo Securities, LLC acted as an active joint book-running manager for Humana Inc.'s Junior Subordinated Notes Offering.
The Junior Subordinated Notes Offering was made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission.
Copies of the prospectus and related prospectus supplement for the Junior Subordinated Notes Offering can be obtained from Goldman Sachs & Co. LLC.
Copies of the prospectus and related prospectus supplement for the Junior Subordinated Notes Offering can be obtained from J.P. Morgan Securities LLC.
Copies of the prospectus and related prospectus supplement for the Junior Subordinated Notes Offering can be obtained from Mizuho Securities USA LLC.
Copies of the prospectus and related prospectus supplement for the Junior Subordinated Notes Offering can be obtained from Truist Securities, Inc.
Copies of the prospectus and related prospectus supplement for the Junior Subordinated Notes Offering can be obtained from Wells Fargo Securities, LLC.
An electronic copy of the registration statement and prospectus supplement for the Junior Subordinated Notes Offering is available on the SEC's website.
The news release does not constitute an offer to sell or a solicitation of an offer to buy the described securities.
There shall be no sale of these securities in any state or jurisdiction where such an offer, solicitation, or sale would be unlawful prior to registration or qualification.
Risks, uncertainties, and assumptions are detailed in the "Risk Factors" section of Humana Inc.'s SEC filings.
Humana Inc.'s profitability could be materially adversely affected if it does not design and price its products properly and competitively.
Humana Inc.'s profitability could be materially adversely affected if premiums are insufficient to cover healthcare service costs.
Humana Inc.'s profitability could be materially adversely affected if it cannot implement clinical initiatives to improve member experience, lower costs, and document risk profiles.
Humana Inc.'s profitability could be materially adversely affected if its estimates of benefits expense are inadequate.
Humana Inc. estimates benefit expense payments and prices products using actuarial methods and assumptions.
Actuarial methods and assumptions used by Humana Inc. are based on claim payment patterns, medical cost inflation, and historical developments.
Humana Inc. continually reviews estimates of future payments for benefit expenses.
Humana Inc. makes necessary adjustments to its reserves, including premium deficiency reserves.
Humana Inc.'s estimates involve extensive judgment and have considerable inherent variability.
Humana Inc.'s estimates are extremely sensitive to changes in claim payment patterns and medical cost trends.
Humana Inc.'s reserves may be insufficient.
Humana Inc.'s business may be materially adversely affected if it fails to implement operational and strategic initiatives effectively.
Humana Inc.'s Medicare initiatives are of particular importance due to revenue concentration in these products.
Humana Inc.'s operational and strategic initiatives include its state-based contract strategy.
Humana Inc.'s operational and strategic initiatives include the growth of its CenterWell business.
Humana Inc.'s operational and strategic initiatives include its integrated care delivery model.
The number of Humana Inc.'s Medicare Advantage plans rated 4-star or higher significantly declined in 2025.
Humana Inc. filed a lawsuit to set aside and vacate its 2025 Medicare Advantage Star Ratings.
On October 14, 2025, a Court rejected Humana Inc.'s challenge to its 2025 Medicare Advantage Star Ratings.
Humana Inc. has appealed the Court's decision regarding its 2025 Medicare Advantage Star Ratings.
There are no assurances Humana Inc. will prevail in the lawsuit regarding its 2025 Medicare Advantage Star Ratings.
If Humana Inc. is not successful in its lawsuit, the decline in Star Ratings will negatively impact its 2026 quality bonus payments from CMS.
If Humana Inc. is not successful in its lawsuit, the decline in Star Ratings may significantly adversely affect its revenues, operating results, and cash flows.
There are no assurances Humana Inc. will be successful in maintaining or improving its Star Ratings in future years.
Humana Inc.'s business may be materially adversely affected if it or its third-party service providers fail to maintain data integrity.
Humana Inc.'s business may be materially adversely affected if it or its third-party service providers fail to maintain existing or implement new information systems.
Humana Inc.'s business may be materially adversely affected if it or its third-party service providers fail to protect proprietary rights to its systems.
Humana Inc.'s business may be materially adversely affected if it or its third-party service providers fail to defend against cybersecurity attacks.
Humana Inc.'s business may be materially adversely affected if it or its third-party service providers fail to contain cybersecurity attacks when they occur.
Humana Inc.'s business may be materially adversely affected if it or its third-party service providers fail to prevent privacy or data security incidents resulting in security breaches.
Humana Inc.'s business may be materially adversely affected if security breaches disrupt company operations.
Humana Inc.'s business may be materially adversely affected if security breaches result in unintentional dissemination of sensitive personal or proprietary information.
Humana Inc.'s information systems may include systems powered by or incorporating artificial intelligence (AI) or machine learning (ML).
Humana Inc. is involved in various legal actions and disputes.
Legal actions and disputes involving Humana Inc. include provider contract disputes and qui tam litigation.
Humana Inc. is subject to governmental and internal investigations.
Unfavorable resolution of legal actions, disputes, or investigations could result in substantial monetary damages for Humana Inc.
Unfavorable resolution of legal actions, disputes, or investigations could result in changes in Humana Inc.'s business practices.
Increased litigation and negative publicity could increase Humana Inc.'s cost of doing business.
As a government contractor, Humana Inc. is exposed to risks that may materially adversely affect its business.
Risks for Humana Inc. as a government contractor include loss of material government contracts.